Metropolis Healthcare Ltd acquires Kolhapur's Ambika Pathology Laboratory

Ameera Shah-led Metropolis Healthcare Limited (NSE: METROPOLIS | BSE: 542650), India's second-largest and most respected pathology laboratory chain, today announced the completion of its fourth acquisition in the last 10 months, with Dr. R.S. Patil's Ambika Pathology Laboratory ("Ambika Pathology") in Kolhapur joining the Metropolis network. Founded and operated by Dr. Rajendra Sadashiv Patil, the NABL-accredited facility is among the region's leading diagnostic providers and has been acquired through a Business Transfer Agreement. This marks a key milestone in Metropolis' "String of Pearls" strategy, which focuses on building strong regional clusters and expanding access to advanced diagnostics across India.

Established in 1995, Ambika Pathology Laboratory has built a strong reputation for quality, accuracy, and patient-centric care. The facility operates a central laboratory supported by 12 patient touchpoints and offers a comprehensive portfolio of tests. With nearly 75% of its revenue derived from B2C walk-in patients, Ambika has earned the trust of both patients and clinicians across Kolhapur and neighbouring towns. Its strong local connect makes it a strategic addition to Metropolis' Western Maharashtra cluster, where the company already operates 19 laboratories across Pune, Kolhapur, Sangli, Satara, Solapur, Nashik, and Ahmednagar, supported by more than 200 patient service centres and a growing franchise network.

Commenting on the acquisition, Ms. Ameera Shah, Promoter and Executive Chairperson, Metropolis Healthcare Limited said: "Maharashtra continues to be a key growth market for Metropolis, contributing nearly 40% of our total revenues. The acquisition of Ambika Pathology further strengthens our Western Maharashtra cluster and supports our ambition to make high-quality diagnostics accessible to more communities. At Metropolis, we are committed to building the diagnostics network of the future, rooted in science, powered by technology, and connected deeply with local healthcare ecosystems. Ambika's strong legacy and trusted regional presence make it a natural fit within our expanding B2C network, and we are delighted to welcome Dr. Rajendra Patil and his team into the Metropolis family."

Mr. Surendran Chemmenkotil, Managing Director, Metropolis Healthcare Limited said: "Our network expansion, through both organic and inorganic growth, is a strategic step towards reshaping how diagnostics is delivered in India. Kolhapur is an important healthcare hub, and the integration of Ambika Pathology Laboratory provides a formidable base to serve patients and clinicians more comprehensively. Ambika's facility will be developed into a mini regional reference lab, strengthening our specialised diagnostics capabilities in the region. Our focus remains on seamless integration, operational excellence, and digital innovation to build connected regional clusters that deliver world-class diagnostics and enable faster, more accurate insights for better patient outcomes."

Dr. Rajendra Patil, Founder and Chief of Lab, Ambika Pathology, Laboratory, said: "Partnering with Metropolis marks a significant milestone, as it brings global standards of science, technology, and operational excellence to our region. This collaboration will not only widen the scope of specialised tests available in Kolhapur but also create new opportunities for medical professionals and patients to benefit from advanced diagnostic innovations. We are confident that Ambika's local legacy, combined with Metropolis' scale and expertise, will set new benchmarks in diagnostic services for Western Maharashtra."

Shares of Metropolis Healthcare Limited was last trading in BSE at Rs. 2045.65 as compared to the previous close of Rs. 2050.65. The total number of shares traded during the day was 1563 in over 337 trades.

The stock hit an intraday high of Rs. 2078.60 and intraday low of 2038.80. The net turnover during the day was Rs. 3203350.00.

Source : Equity Bulls

Keywords

MetropolisHealthcare INE112L01020 HealthcareServices Acquisition AmbikaPathologyLaboratory Kolhapur